OVARIAN CANCER

Surgery

According to a medical examination and transvaginal ultrasound findings suspected ovarian cancer is often a laparotomy to be confirmed histology, and tumor stage and tumor debulking surgery. Histological need to be certified to remove ovarian cysts Mixed other causes, including non - epithelial ovarian cancer (such as interstitial or germ cell tumors), other primary site of tumor metastasis to the ovary (such as the adhesion of), or benign lesions, such as endometriosis. The adhesion is usually of signet ring cell tumor, representatives from primary adenocarcinoma of the stomach metastatic ovarian cancer. However, other parts of the original cancer, such as colon, appendix, the gallbladder and breast (special lobular invasive carcinoma) will also transfer to ovarian. At laparotomy surgery during the stage, right after the decision-making guidance provided important information, especially for patients with early (discussed below). Finally, the tumor debulking surgery (initial cytoreductive surgery) is the first of an important part of the operation because of residual tumor with a diameter of less than 1 cm larger than the residual tumor with a high survival rate.

Tags: abdominal, age, benign, bleeding, body, breast, cancer, carboplatin, carcinoma, care, cases, cause, cell, chemotherapy, cisplatin, clinical, cyst, cysts, diagnosis, drug, drugs, early, eat, ert, examination, exploration, gene, group, increased, intravenous, life, lymph, metastasis, metastatic, method, node, ovarian, ovary, paclitaxel, patients, pelvic, physical, poor, prognosis, quality, radiation, radiotherapy, rate, reduce, resection, residual, risk, screening, second, skin, staging, surface, surgery, surgical, survival, symptoms, syndrome, taxol, tea, therapy, time, treatment, tumor, tumors, usually, uterine

Abstract: The FDA approved a new treatment of advanced ovarian cancer on the first line of the short-term treatment programs, in the treatment of cisplatin infusion again, Bristol-Myers Squibb pharmaceutical factories paclitaxel (Taxol) 3 hours.

The United States Food and Drug Administration (FDA) approved a new treatment of advanced ovarian cancer on the first line of the short-term treatment programs, in the treatment of cisplatin injection again, Bristol-Myers Squibb pharmaceutical factories paclitaxel (Taxol) 3 hours.

Tags: administration, age, anti, blood, breast, cancer, cell, cells, cisplatin, clinical, drug, drugs, eat, fat, grams, head, infusion, injection, neck, ovarian, paclitaxel, patients, radiotherapy, reduce, risk, study, taxol, therapy, toxicity, treatment, women

A benign ovarian tumors young patients affected Annex tumor resection or stripped of. If both bilateral ovarian tumors, should fight to retain part of normal ovarian tissue. Before post-clearance as abdominal specimens suspected malignant sent frozen biopsy. Patients before and after menopause to be hysterectomy and bilateral resection of the Annex to activities.

2, malignant ovarian tumor treatment to the main, supplemented by chemotherapy, and radiotherapy.

(1) to general surgery for hysterectomy, bilateral Annex and the omentum resection. Patients with advanced cancer should be possible for the transfer to that reduction of tumor cells. As for retroperitoneal lymph node removal of the therapeutic value can not be determined.

Tags: abdominal, age, annex, anti, benign, cancer, cell, cells, chemotherapy, cisplatin, days, dose, drug, drugs, eat, ert, exploration, gene, grams, infusion, injection, intraperitoneal, intravenous, irradiation, lymph, malignant, node, ovarian, patients, protein, radiation, radiotherapy, rate, reduce, resection, residual, surgery, surgical, survival, therapy, time, toxicity, treatment, tumor, tumors, usually

Taxol is more 1990s, the treatment of advanced ovarian cancer drug effective, and its unique mechanism is a new type of anti-tubulin role of antitumor drugs. Cisplatin for inorganic platinum metal complex, the cell cycle-specific drug, can inhibit DNA synthesis, combined with their synergies to enhance the effectiveness of [1]. In Division I from July 1996 to July 1998 to 15 cases of advanced ovarian cancer patients with Taxol and cisplatin in the treatment of satisfactory results.

Tags: administration, age, anti, blood, body, cancer, care, cases, cause, cell, chemotherapy, cisplatin, confidence, days, diet, dose, drug, drugs, eat, ert, gene, group, growth, incidence, infusion, injection, intravenous, life, metastasis, method, ovarian, paclitaxel, pain, patients, poor, psychological, rate, reduce, response, skin, surface, surgery, survival, symptoms, taxol, therapy, time, toxicity, treatment, tumor, tumors, women

Ovarian cancer is one of the female genital common tumor, the treatment of surgical resection mainly, but because of the lack of effective early ovarian cancer diagnostic methods, to the late effects of surgery are often poor, I begin by 1994, 41 cases of ovarian cancer patients percutaneous internal iliac aneurysms of the chemotherapy, and has achieved recent good results.

An information and methods <BR> <BR> 1.1 general information 41 patients, 12 cases of pregnancy, aged 25 to 56 years old, are bloating, abdominal pain, ascites and other symptoms, the CT or ultrasound for ovarian cancer are diagnosed and into intervention Branch.

Tags: abdominal, administration, age, anti, bleeding, blood, cancer, cases, cause, chemotherapy, cisplatin, drug, drugs, early, eat, examination, fat, gene, injection, intraperitoneal, intravenous, mass, method, oppression, ovarian, pain, patients, poor, resection, response, skin, surgery, surgical, symptoms, therapy, time, toxicity, treatment, tumor, tumors

"Nursing Care of Patients Treated With Combination Oophoroma of Taxolr and Platinum" ovarian cancer in the female genital cancer incidence rate of the two, but the mortality rate is the one. According to information at home and abroad, the survival rate of patients 5a about 30%, 70% have advanced at diagnosis [1]. Currently the disease is a better treatment after surgery and adjuvant chemotherapy. I Branch in 1996 -1997, will Taxol and cisplatin in the treatment of ovarian cancer <BR> made good effect, even on the platinum resistance there are still 20% to 30% effective. Now Taxol treatment care summarized as follows:
A clinical data and methods
1.1 clinical data: 12 patients had been diagnosed with ovarian cancer. Age 18 to 68 years old, with an average age of 43 years. Thailand used in the treatment of a total of 24 courses, the average two courses. Only two courses for Taxol alone, the rest are combined, each treatment separated three weeks to four weeks.
1.2 treatment:
1.2.1 before chemotherapy treatment: 6 hours respectively before treatment, 12 hours of oral dexamethasone 20 mg, in the half-hour before administration of oral and intravenous diphenhydramine 50 mg and cimetidine 300 mg to prevent the occurrence of allergic reactions.
1.2.2 drug preparation: Thailand concentrated on the use of PVC with a syringe preparation will liquid two phthalic acid ethyl of increase [2]. It increases in drug use should be used glass and stainless steel syringe needles, and the infusion of special filters are allocated are spent. As the Taxol is a cell-like anti-cancer drugs, so nurses in the preparation and administration must pay attention to self-protection, gloves, masks, if the skin or mucosa by pollution, should be thoroughly cleaned immediately with soap or water rinse [2].

Tags: administration, age, anti, cancer, care, cell, chemotherapy, cisplatin, clinical, diagnosis, drug, drugs, eat, incidence, infusion, intravenous, method, ovarian, patients, rate, skin, surgery, survival, taxol, therapy, treatment

According to an obstetrics and gynecology oncology groups (GOG) study said that the smaller Phase III epithelial ovarian cancer patients, carboplatin and Taxol toxicity smaller, easier to use, the effect is less than cisplatin plus paclitaxel.

The non-randomized study data show that in advanced epithelial ovarian cancer, carboplatin and paclitaxel very effective, but less than the toxicity of cisplatin-based drugs, but its smaller, have unresectable Stage III cancer effects remain unknown. To this end, Philadelphia Fox Kaiser Cancer Center Aozhuoershi (Robert F. Ozols), and colleagues conducted a test to detect carboplatin and paclitaxel combined with cisplatin is secondary. 792 patients participated in this study, 400 were randomly assigned cisplatin (75 mg/m2) and paclitaxel (135 mg/m2) 24-hour infusion (group I), 392 with carboplatin (area under the curve of 7.5) and paclitaxel (175 mg / m2) 3-hour infusion (Group II). The two groups were 85% and 87% of the patients completed six cycles of treatment.

Tags: age, blood, cancer, carboplatin, cell, cisplatin, clinical, drug, drugs, eat, ert, group, groups, gynecological, infusion, ovarian, paclitaxel, patients, rate, second, study, survival, taxol, time, toxicity, treatment

Ovarian cancer is very common, all ages can ill, but 20 to 50 years old the most. Since early ovarian cancer patients have few symptoms, so early diagnosis difficult, attendance at the 70% already advanced, little access to early treatment, five-year survival rate always hovering in the 20 ~ 30%, is the most serious threat to women's lives malignant one.

One, classification

Tags: abdominal, administration, age, amenorrhea, annex, anti, benign, bleeding, blood, body, cancer, carcinoma, cases, cause, cell, cells, chemotherapy, children, cisplatin, clinical, cyst, cystic, cysts, diagnosis, drug, drugs, early, eat, ert, examination, exploration, gene, group, growth, gynecological, history, incidence, increased, injection, intraperitoneal, irradiation, lymph, malignant, mass, metastasis, metastatic, method, node, oppression, ovarian, pain, patients, pelvic, poor, positive, powder, protein, radiation, radiotherapy, rate, reduce, resection, residual, response, second, study, surface, surgery, surgical, survival, symptoms, therapy, time, treatment, tumor, tumors, uterine, women

Whitney physicians that cisplatin / paclitaxel chemotherapy in the treatment of ovarian cancer treatment should become the new standard.

Carboplatin / taxol treatment programs, and the current phase III epithelial ovarian tumors standard chemotherapy - cisplatin / paclitaxel, the same as its efficacy, toxicity small. Experts believe that the program should become a new standard treatment programs.

Combination of paclitaxel and cisplatin, paclitaxel must be sustained 24-hour infusion, and Taxol and carboplatin compatibility, 3-hour infusion of paclitaxel can, thus reducing low toxic side effects to a large extent.

Tags: age, cancer, carboplatin, cases, cause, chemotherapy, cisplatin, clinical, drug, early, eat, ert, exploration, grams, group, infusion, injection, method, ovarian, paclitaxel, pain, patients, prognosis, rate, residual, risk, second, study, surgery, survival, taxol, therapy, toxicity, treatment, tumor, tumors